The DOI matches its Crossref record.
Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A retrospective comparison suggested improved mortality with myectomy over ASA, but referral bias cannot be excluded.65”
From Current management of hypertrophic cardiomyopathy (2025) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 32
- Maron, 2006, Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction, Circulation, 114, 2232, 10.1161/CIRCULATIONAHA.106.644682 · DOI
- Geske, 2017, Women with hypertrophic cardiomyopathy have worse survival, Eur Heart J, 38, 3434, 10.1093/eurheartj/ehx527 · DOI
- Ommen, 2020, 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, J Am Coll Cardiol, 76, e159, 10.1016/j.jacc.2020.08.045 · DOI · Paper page
- Ommen, 2005, Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, 46, 470, 10.1016/j.jacc.2005.02.090 · DOI
- Batzner, 2018, Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy, J Am Coll Cardiol, 72, 3087, 10.1016/j.jacc.2018.09.064 · DOI · Paper page
- Sorajja, 2008, Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation, 118, 131, 10.1161/CIRCULATIONAHA.107.738740 · DOI
- ten Cate, 2010, Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution, Circ Heart Fail, 3, 362, 10.1161/CIRCHEARTFAILURE.109.862359 · DOI
- Steggerda, 2014, Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience, J Am Coll Cardiol Intv, 7, 1227, 10.1016/j.jcin.2014.05.023 · DOI
- Nguyen, 2019, Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a propensity score-matched cohort, J Thorac Cardiovasc Surg, 157, 306, 10.1016/j.jtcvs.2018.08.062 · DOI
- Kimmelstiel, 2019, Guideline-based referral for septal reduction therapy in obstructive hypertrophic cardiomyopathy is associated with excellent clinical outcomes, Circ Cardiovasc Interv, 12, 10.1161/CIRCINTERVENTIONS.118.007673 · DOI
- Olivotto, 2007, Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?, J Am Coll Cardiol, 50, 831, 10.1016/j.jacc.2007.05.018 · DOI
- Alam, 2009, Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis, Eur Heart J, 30, 1080, 10.1093/eurheartj/ehp016 · DOI
- Agarwal, 2010, Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy, J Am Coll Cardiol, 55, 823, 10.1016/j.jacc.2009.09.047 · DOI
- Gersh, 2011, 2011 ACCF/aha guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 58, e212, 10.1016/j.jacc.2011.06.011 · DOI · Paper page
- Said, 2013, Surgical treatment of hypertrophic cardiomyopathy, Expert Rev Cardiovasc Ther, 11, 617, 10.1586/erc.13.46 · DOI
- Wang, 2016, Excision of anomalous muscle bundles as an important addition to extended septal myectomy for treatment of left ventricular outflow tract obstruction, J Thorac Cardiovasc Surg, 152, 461, 10.1016/j.jtcvs.2016.01.051 · DOI
- Yuan, 2010, Follow-up by cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy who underwent percutaneous ventricular septal ablation, Am J Cardiol, 106, 1487, 10.1016/j.amjcard.2010.07.017 · DOI
- Rastegar, 2017, Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience, Ann Cardiothorac Surg, 6, 353, 10.21037/acs.2017.07.07 · DOI
- Sorajja, 2012, Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation, 126, 2374, 10.1161/CIRCULATIONAHA.111.076257 · DOI
- Kim, 2016, Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US Nationwide Inpatient Database, 2003-2011, JAMA Cardiol, 1, 324, 10.1001/jamacardio.2016.0252 · DOI
- Maron, 2015, Low operative mortality achieved with surgical septal myectomy: role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction, J Am Coll Cardiol, 66, 1307, 10.1016/j.jacc.2015.06.1333 · DOI · Paper page
- Valeti, 2007, Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy, J Am Coll Cardiol, 49, 350, 10.1016/j.jacc.2006.08.055 · DOI
- Lu, 2016, Predictors of outcome after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: an echocardiography and cardiovascular magnetic resonance imaging study, Circ Cardiovasc Interv, 9, 10.1161/CIRCINTERVENTIONS.115.002675 · DOI
- Veselka, 2019, Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis, Eur Heart J, 40, 1681, 10.1093/eurheartj/ehz110 · DOI
- Fifer, 2007, Most fully informed patients choose septal ablation over septal myectomy, Circulation, 116, 207, 10.1161/CIRCULATIONAHA.107.688135 · DOI
- Maron, 2007, Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy, Circulation, 116, 196, 10.1161/CIRCULATIONAHA.107.691378 · DOI
- Fifer, 2018, Septal reduction therapy for hypertrophic obstructive cardiomyopathy, J Am Coll Cardiol, 72, 3095, 10.1016/j.jacc.2018.10.013 · DOI
- Cui, 2019, Conduction abnormalities and long-term mortality following septal myectomy in patients with obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, 74, 645, 10.1016/j.jacc.2019.05.053 · DOI
- Greason, 2017, Long-term mortality effect of early pacemaker implantation after surgical aortic valve replacement, Ann Thorac Surg, 104, 1259, 10.1016/j.athoracsur.2017.01.083 · DOI
- Flores-Ramirez, 2001, Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy, J Am Coll Cardiol, 37, 208, 10.1016/S0735-1097(00)01045-7 · DOI
- Sorajja, 2009, Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study, J Am Coll Cardiol, 54, 234, 10.1016/j.jacc.2009.01.079 · DOI
- Quintana, 2015, Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy?, J Thorac Cardiovasc Surg, 150, 159, 10.1016/j.jtcvs.2015.03.044 · DOI
Cited by
Sorted by citations
Current management of hypertrophic cardiomyopathy
Sikand, N., Stendahl, J., Sen, S., Lampert, R., & Day, S. (2025) · BMJ · doi:10.1136/bmj-2023-077274 · Cited by 26
Metadata
- Authors
- Cui, H., Schaff, H. V., Wang, S., Lahr, B. D., Rowin, E. J., Rastegar, H., Hu, S., Eleid, M. F., Dearani, J. A., Kimmelstiel, C., Maron, B. J., Nishimura, R. A., Ommen, S. R., & Maron, M. S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 79
- Issue
- 17
- Pages
- 1647-1655
- ISSN
- 0735-1097
- Cited by
- 113
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy. https://app.cochat.ai/papers/10.1016/j.jacc.2022.02.032
- The paper
- Cui, H., Schaff, H. V., Wang, S., Lahr, B. D., Rowin, E. J., Rastegar, H., Hu, S., Eleid, M. F., Dearani, J. A., Kimmelstiel, C., Maron, B. J., Nishimura, R. A., Ommen, S. R., & Maron, M. S. (2022). Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2022.02.032